NCT00462813View on ClinicalTrials.gov

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

PHASE3CompletedINTERVENTIONAL
Enrollment

3,000

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

June 30, 2008

Study Completion Date

January 31, 2010

Conditions
Cervical CancerPrecancerous Condition
Interventions
DRUG

oral microencapsulated diindolylmethane

GENETIC

polymerase chain reaction

OTHER

cervical Papanicolaou test

OTHER

cytology specimen collection procedure

PROCEDURE

colposcopic biopsy

Trial Locations (2)

EC1M 6BQ

Barts and the London School of Medicine, London

CF14 4XW

University Hospital of Wales, Cardiff

All Listed Sponsors
lead

Barts and the London School of Medicine and Dentistry

OTHER

NCT00462813 - Diindolylmethane in Treating Patients With Abnormal Cervical Cells | Biotech Hunter | Biotech Hunter